Showing results (331-340 of 386) with videos related to

Sort By:
Pageof 39
Clinical Epigenetics|November 25, 2018
A urine-based DNA methylation assay, ProCUrE, to identify clinically significant prostate cancerFang Zhao, Ekaterina Olkhov-Mitsel, Shivani Kamdar, et al.
Oncotarget|May 3, 2017
Metabolic heterogeneity signature of primary treatment-naïve prostate cancerDong Lin, Susan L Ettinger, Sifeng Qu, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|March 1, 2014
Growth kinetics of small renal masses: A prospective analysis from the Renal Cell Carcinoma Consortium of CanadaMichael Organ, Michael Jewett, Joan Basiuk, et al.
European Urology Focus|July 5, 2020
The Suggested Unique Association Between the Various Statin Subgroups and Prostate CancerHanan Goldberg, Faizan K Mohsin, Refik Saskin, et al.
The Journal of Urology|May 15, 2018
Evaluation of an Aggressive Prostate Biopsy Strategy in Men Younger than 50 YearsHanan Goldberg, Zachary Klaassen, Thenappan Chandrasekar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 4, 2026
131I-LNTH-1095 Radioligand Therapy Plus Enzalutamide vs. Enzalutamide Alone in Men With PSMA-Avid Metastatic Castration-Resistant Prostate Cancer: A Phase 2 StudyEvan Y Yu, Vivek Narayan, Giuseppe Esposito, et al.
The Journal of Molecular Diagnostics : JMD|March 6, 2016
Application of a Clinical Whole-Transcriptome Assay for Staging and Prognosis of Prostate Cancer Diagnosed in Needle Core Biopsy SpecimensBeatrice S Knudsen, Hyung L Kim, Nicholas Erho, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 15, 2017
Propensity Score Analysis of Radical Cystectomy Versus Bladder-Sparing Trimodal Therapy in the Setting of a Multidisciplinary Bladder Cancer ClinicGirish S Kulkarni, Thomas Hermanns, Yanliang Wei, et al.
Pageof 39